Standout Papers

Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies 2025 202616
  1. Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies (2025)
    Yan-Ruide Li, Ying Fang et al. Nature Communications

Immediate Impact

3 by Nobel laureates 61 standout
Sub-graph 1 of 22

Citing Papers

Strategic advancements in targeting the PI3K/AKT/mTOR pathway for Breast cancer therapy
2025 Standout
Distinct cellular mechanisms underlie chemotherapies and PD-L1 blockade combinations in triple-negative breast cancer
2025 Standout
2 intermediate papers

Works of Yan-Ruide Li being referenced

Immune evasion in cell-based immunotherapy: unraveling challenges and novel strategies
2024
Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy
2021

Author Peers

Author Last Decade Papers Cites
Yan-Ruide Li 444 362 225 43 707
Árpád Szöőr 448 210 272 57 732
Megan M. Wyatt 512 420 183 28 739
Patrick C. Gedeon 509 278 212 27 753
Nicole Berndt 450 359 268 34 775
Marc Wehrli 337 389 349 23 788
Johanna Theruvath 368 310 213 21 684
Kyle Dyson 406 278 218 19 749
Kevin Bielamowicz 448 194 155 26 640
Kristina Wikström 392 217 257 22 659
Qian Zhang 576 245 290 30 842

All Works

Loading papers...

Rankless by CCL
2026